Lifetime Management in light of 2025 ESC/EACTS Guidelines

 

Chairs

C. Carranza

M. Borger

 

Agenda

  • 12.15 – Impact of the 2025 ESC/EACTS Guidelines on heart valve disease treatment – Michael Borger, Germany
  • 12.30 – Next-generation bioprostheses in SAVR: A propensity-matched 8-year outcome study -Vinod Thourani, USA
  • 12.45 – Designing durable pathways in the management of aortic valvular heart disease – Jessica Forcillo, Canada
  • 13.00 – Case-based exploration of modern lifetime valve strategies – Christian Carranza, Denmark
  • 13.15 – Discussion – Panel
Go Back to Symposia Programme Visit the Full Scientific Programme